- UroToday Home
- Recent Abstracts
- Pelvic Health & Reconstruction
Overactive Bladder
Guidelines for practical usage of botulinum toxin type A (BoNTA) for refractory idiopathic overactive bladder management - Abstract
December 17, 2013
Autonomic nervous system alteration in multiple sclerosis patients with urinary symptoms. Clinical, urodynamic and cardiovascular study - Abstract
December 16, 2013
Estimating EQ-5D and OAB-5D health state utilities for patients with overactive bladder - Abstract
December 13, 2013
Long term follow up of sacral neuromodulation for lower urinary tract dysfunction - Abstract
December 13, 2013
A phase 2, randomized, double-blind, efficacy and safety study of oxybutynin vaginal ring for alleviation of overactive bladder symptoms in women - Abstract
December 12, 2013
Ultrasound assessment of bladder wall thickness as a screening test for detrusor instability - Abstract
December 9, 2013
Use of herbal supplements for overactive bladder - Abstract
December 6, 2013
Overactive bladder in cervical spondylotic myelopathy - Abstract
December 5, 2013
Evaluation of fesoterodine fumarate for the treatment of an overactive bladder - Abstract
December 3, 2013
Antimuscarinic persistence patterns in newly treated patients with overactive bladder: A retrospective comparative analysis - Abstract
December 2, 2013
Preparation and evaluation of once-daily sustained-release coated tablets of tolterodine-L-tartrate - Abstract
November 29, 2013
Urinary bladder drugs - Abstract
November 28, 2013
Electrical and mechanical office-based neuromodulation - Abstract
November 26, 2013
Important drug-drug interactions for treatments that target overactive bladder syndrome - Abstract
November 26, 2013